We raise our TP by 21% and upgrade our rating from OUTPERFORM to BUY as we are optimistic that DCM will benefit from strong urea prices in 2021-2022F while rising export demand and the company’s NPK segment are potential medium-term earnings drivers

Powered by Froala Editor